AstraZeneca Has an $80 Billion Dream and a Plan to Fix Its Stalling Stock

AstraZeneca Has an $80 Billion Dream and a Plan to Fix Its Stalling Stock

来源:Barrons发布于 2026-10-30

AstraZeneca aims to free up funds to reinvest into its pipeline and meet its goal of $80 billion in annual revenue by 2030.

相关标的:AZN

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。